OECD warns high-priced drugs are stretching health budgets

LONDON (Reuters) - Speciality medicines for which pharmaceutical companies demand high prices are straining wealthy nations' health budgets, the OECD said on Wednesday, with drugs accounting for some 20 percent of all health spending.